TP53 Mutation Status Divides MDS Patients with Complex Karyotypes into Distinct Prognostic Risk Groups: Analysis of Combined Datasets from the International Working Group for MDS-Molecular Prognosis Committee
Year: 2014
Type: conference-abstract
Source: Blood
Authors: Rafael Bejar, Elli Papaemmanuil, Torsten Haferlach, Guillermo Garcia-Manero, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Matthew J. Walter, Timothy A. Graubert, Mario Cazzola, Luca Malcovati, Peter J Campbell, Seishi Ogawa, Jacqueline Boultwood, David Bowen, Sudhir Tauro, Michael J Groves, Michaela Fontenay, Lee-Yung Shih, Heinz Tüchler, Kristen E. Stevenson, Donna Neuberg, Peter L. Greenberg, Benjamin L. Ebert
Institutions: University of California San Diego, Moores Cancer Center, Wellcome Sanger Institute, Munich Leukemia Laboratory (Germany), The University of Texas MD Anderson Cancer Center, Cleveland Clinic, Washington University in St. Louis, Harvard University, Massachusetts General Hospital, University of Pavia, Policlinico San Matteo Fondazione, Kyoto University, John Radcliffe Hospital, Leeds Teaching Hospitals NHS Trust, Ninewells Hospital, Assistance Publique – Hôpitaux de Paris, Chang Gung Memorial Hospital, Dana-Farber Cancer Institute, Stanford University, Brigham and Women's Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2528909563